CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium

Core Insights - CeriBell's technology addresses critical challenges in diagnosing non-convulsive seizures in acute care settings, with 92% of seizures in ICU and ED patients being non-convulsive, making EEG essential for diagnosis [2][4] - The company reported $89 million in revenue for 2025, reflecting a 36% year-over-year growth and achieving 88% gross margins, with a total addressable market (TAM) expansion from $2 billion to approximately $3.5 billion [3][6][7] Company Overview - CeriBell is focused on accelerating the adoption of its point-of-care EEG platform in U.S. hospitals while expanding into new patient populations and indications [4] - The commercial model includes approximately 25% subscription revenue with a gross margin of about 97% and around 75% revenue from disposable headbands [5][18] Market Expansion - The company has received FDA clearance for pediatric and neonatal use, with a launch planned for Q2, representing a market expansion opportunity of roughly $400 million [9][10] - CeriBell's long-term vision includes becoming the standard of care for seizure detection and expanding its platform to include algorithms for delirium and stroke [14][15] Adoption and Growth Strategy - Despite achieving 31 consecutive quarters of sequential growth, CeriBell has only penetrated about 3% of the U.S. seizure market, indicating significant upside potential [7][12] - The company has expanded its territory manager coverage from approximately 35 to 55 territories, enhancing its go-to-market execution [13] Competitive Position - CeriBell is positioned as a market leader and category creator in EEG technology, with a focus on algorithm capabilities and a multi-indication platform approach [21] - The company emphasizes that once implemented, accounts require minimal maintenance, making it difficult for competitors to displace [19][20] Financial Health - CeriBell reported $159 million in capital post-IPO, with a focus on maintaining flexibility without the need for additional capital raises [22]